BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Samo S, Bansal A. The Risk of Barrett’s Esophagus Transforming to Esophageal Cancer. Foregut: The Journal of the American Foregut Society 2022. [DOI: 10.1177/26345161221143140] [Reference Citation Analysis]
2 Meyer C, Hejazi R, Bansal A. How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. Curr Opin Gastroenterol 2021;37:378-83. [PMID: 33883421 DOI: 10.1097/MOG.0000000000000743] [Reference Citation Analysis]
3 Vieth M. Pathophysiologie und Klassifikationen von Barrett-Metaplasie und -Dysplasie des Ösophagus. Benigne Ösophaguserkrankungen 2021. [DOI: 10.1007/978-3-662-60455-7_24] [Reference Citation Analysis]
4 Chuy J, Kornblum N. Esophageal Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_78] [Reference Citation Analysis]
5 Chuy J, Kornblum N. Esophageal Cancer. Geriatric Gastroenterology 2020. [DOI: 10.1007/978-3-319-90761-1_78-1] [Reference Citation Analysis]
6 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 14.0] [Reference Citation Analysis]
7 Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal Tract Disorders in Older Age. Can J Gastroenterol Hepatol 2019;2019:6757524. [PMID: 30792972 DOI: 10.1155/2019/6757524] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
8 Pecere S, Costamagna G. Endoscopic therapy for confirmed low-grade dysplasia in Barrett's esophagus. Transl Gastroenterol Hepatol 2018;3:83. [PMID: 30505970 DOI: 10.21037/tgh.2018.10.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Harrison M, Allen JE, Gorrepati VS, López-Jamar JME, Sharma P. Management of Barrett's esophagus with low-grade dysplasia. Dis Esophagus 2018;31. [PMID: 29506235 DOI: 10.1093/dote/doy004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
10 Westerveld D, Khullar V, Mramba L, Ayoub F, Brar T, Agarwal M, Forde J, Chakraborty J, Riverso M, Perbtani YB, Gupte A, Forsmark CE, Draganov P, Yang D. Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis. Endosc Int Open 2018;6:E300-7. [PMID: 29507870 DOI: 10.1055/s-0044-101351] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
11 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]